Interventional reperfusion for pulmonary embolism
The management of patients with intermediate-risk pulmonary embolism (PE) has evolved in recognition of this unique population’s potential for circulatory collapse. Systemic thrombolysis, catheter-directed thrombolysis (CDT), and mechanical thrombectomy are reperfusion therapies typically reserved for patients with high-risk PE. Intermediate-risk PE represents a dynamic pathophysiologic state, whereby right ventricular dysfunction (RVD) may progress to cardiogenic shock in minutes to hours. More recent evidence suggests that early reperfusion for patients with intermediate-risk PE can have a profound impact on mortality (and adverse bleeding events) compared with anticoagulation alone. Anticoagulation is paramount in PE management, although recent trends highlight a reliance on unfractionated heparin despite evidence favoring alternative anticoagulation strategies. Modern perspectives on PE management emphasize early identification of RVD and escalation to interventional reperfusion, using vasoactive medications as a bridge to therapy.
Authors
- Jane Ramos
Publication Details
- Journal
- JAAPA
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1097/01.jaa.0000000000000402
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00